FDA removes risk evaluation and mitigation strategy (REMS) program for the antipsychotic drug Clozapine
Similar Posts
National Drug Code Database Background Information
National Drug Code Database Background InformationPostmarketing Requirements and Commitments: Searchable Database
Learn more about FDA’s Postmarketing Requirements and Commitments Searchable Database.Scientific Protein Laboratories, LLC – 712578 – 10/10/2025
CGMP/Active Pharmaceutical Ingredient (API)/AdulteratedErosive Esophagitis: Developing Drugs for Treatment
Erosive Esophagitis: Developing Drugs for TreatmentCDL Services, Inc. DBA Technichem – 713877 – 11/24/2025
CGMP/Finished Pharmaceuticals/AdulteratedSKNV. Pompano Beach, FL. Untitled Letter issued 09/16/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 09/16/2025
Short Title (70 char) SKNV. Pompano Beach, FL. Untitled Letter issued 09/16/2025
FEI Number 3012384835
Firm Name SKNV
Record Type Untitled Letter
State FL
Establishment Type Outsourcing Facility